136 related articles for article (PubMed ID: 1673544)
21. Quinolinate differentiates between forebrain and cerebellar NMDA receptors.
Monaghan DT; Beaton JA
Eur J Pharmacol; 1991 Feb; 194(1):123-5. PubMed ID: 1676371
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of [3H]L-glutamate uptake from L-glutamate-induced [3H]D-aspartate release by 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid and 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic acid, two conformationally constrained aspartate and glutamate analogs.
Funicello M; Conti P; De Amici M; De Micheli C; Mennini T; Gobbi M
Mol Pharmacol; 2004 Sep; 66(3):522-9. PubMed ID: 15322243
[TBL] [Abstract][Full Text] [Related]
23. Cellular uptake disguises action of L-glutamate on N-methyl-D-aspartate receptors. With an appendix: diffusion of transported amino acids into brain slices.
Garthwaite J
Br J Pharmacol; 1985 May; 85(1):297-307. PubMed ID: 2862941
[TBL] [Abstract][Full Text] [Related]
24. Glutamate uptake system in the presynaptic vesicle: glutamic acid analogs as inhibitors and alternate substrates.
Winter HC; Ueda T
Neurochem Res; 1993 Jan; 18(1):79-85. PubMed ID: 8096630
[TBL] [Abstract][Full Text] [Related]
25. A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-alpha-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord.
Shinozaki H; Ishida M; Shimamoto K; Ohfune Y
Brain Res; 1989 Feb; 480(1-2):355-9. PubMed ID: 2565750
[TBL] [Abstract][Full Text] [Related]
26. Changes in preference for receptor subtypes of configurational variants of a glutamate analog: conversion from the NMDA-type to the non-NMDA type.
Ishida M; Ohfune Y; Shimada Y; Shimamoto K; Shinozaki H
Brain Res; 1991 May; 550(1):152-6. PubMed ID: 1653635
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.
Koch HP; Kavanaugh MP; Esslinger CS; Zerangue N; Humphrey JM; Amara SG; Chamberlin AR; Bridges RJ
Mol Pharmacol; 1999 Dec; 56(6):1095-104. PubMed ID: 10570036
[TBL] [Abstract][Full Text] [Related]
28. A comparative study and partial characterization of multi-uptake systems for gamma-aminobutyric acid.
Wood JD; Sidhu HS
J Neurochem; 1987 Oct; 49(4):1202-8. PubMed ID: 2887634
[TBL] [Abstract][Full Text] [Related]
29. [Effect of ascorbic acid on the binding of 3H-GABA and 3H-glutamic acid to synaptosomes of the rat cerebral cortex].
Grigor'ev IP; Neokesariĭskiĭ AA
Biull Eksp Biol Med; 1986 Sep; 102(9):288-9. PubMed ID: 2875748
[TBL] [Abstract][Full Text] [Related]
30. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer.
Bridges RJ; Stanley MS; Anderson MW; Cotman CW; Chamberlin AR
J Med Chem; 1991 Feb; 34(2):717-25. PubMed ID: 1671706
[TBL] [Abstract][Full Text] [Related]
31. Modulatory action of kainic acid on glutamate release from rat brain cortical synaptosomes.
Solyakov LS; Drany OA; Petrova LN; Bachurin SO
Ann N Y Acad Sci; 1992 May; 648():251-3. PubMed ID: 1353329
[No Abstract] [Full Text] [Related]
32. Release of aspartate and glutamate caused by chloride reduction in synaptosomal incubation media.
Hardy JA; Boakes RJ; Thomas DJ; Kidd AM; Edwardson JA; Virmani M; Turner J; Dodd PR
J Neurochem; 1984 Mar; 42(3):875-7. PubMed ID: 6141228
[TBL] [Abstract][Full Text] [Related]
33. A model of high affinity glutamic acid transport by rat cortical synaptosomes--a refinement of the originally proposed model.
Wheeler DD
J Neurochem; 1979 Oct; 33(4):883-94. PubMed ID: 490163
[No Abstract] [Full Text] [Related]
34. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex.
Montague PR; Gancayco CD; Winn MJ; Marchase RB; Friedlander MJ
Science; 1994 Feb; 263(5149):973-7. PubMed ID: 7508638
[TBL] [Abstract][Full Text] [Related]
35. Glutaminase inhibition and the release of neurotransmitter glutamate from synaptosomes.
Bradford HF; Ward HK; Foley P
Brain Res; 1989 Jan; 476(1):29-34. PubMed ID: 2563333
[TBL] [Abstract][Full Text] [Related]
36. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
[TBL] [Abstract][Full Text] [Related]
37. Arachidonic acid inhibits choline uptake and depletes acetylcholine content in rat cerebral cortical synaptosomes.
Boksa P; Mykita S; Collier B
J Neurochem; 1988 Apr; 50(4):1309-18. PubMed ID: 3126267
[TBL] [Abstract][Full Text] [Related]
38. Glutamate stimulation of 45Ca uptake by rat striatal synaptosomes.
Retz KC; Young AC; Coyle JT
Eur J Pharmacol; 1982 Apr; 79(3-4):319-22. PubMed ID: 6124433
[TBL] [Abstract][Full Text] [Related]
39. Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord.
Shinozaki H; Ishida M; Shimamoto K; Ohfune Y
Br J Pharmacol; 1989 Dec; 98(4):1213-24. PubMed ID: 2692753
[TBL] [Abstract][Full Text] [Related]
40. D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist.
Schoepp DD; Smith CL; Lodge D; Millar JD; Leander JD; Sacaan AI; Lunn WH
Eur J Pharmacol; 1991 Oct; 203(2):237-43. PubMed ID: 1686860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
